CTOs on the Move

Profusa

www.profusa.com

 
Profusa, Inc. is leading the development of a new generation of biologically integrated sensors that empowers an individual with the ability to continuously monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Overcoming the bodys response to foreign material, the companys technology enables the development of minute bioengineered sensors that become one with the body to detect and transmit clinical-grade data for personal and medical use.
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million
  • www.profusa.com
  • 345 Allerton Ave South
    San Francisco, CA USA 94080
  • Phone: 415.655.9861

Executives

Name Title Contact Details

Funding

Profusa raised $13.2M on 12/16/2015
Profusa raised $45M on 08/14/2018

Similar Companies

Velano Vascular

Velano Vascular aims to improve the hospital experience by reducing the pain, anxiety, and inefficiencies of blood draws.

Cardiac Insight

Cardiac Insight, Inc. is a privately held medical device company based in Seattle, WA. Cardiac Insight is developing advanced, body worn ECG sensing technology aimed at the early diagnosis of atrial fibrillation (AF) and other conditions. Earlier last year, the company announced a strategic collaboration with Welch Allyn, now part of the Hill-Rom family of companies, for the distribution rights of certain products and technologies offered by Cardiac Insight.

FBK Medical Tubing

FBK Medical Tubing is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Colorado Serum Company

Colorado Serum Company is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.